VERU INC.
VERU$64M
Micro CapNASDAQPharmaceutical Preparations🇺🇸North AmericaMIAMI
Drugs in Pipeline
4
Phase 3 Programs
1
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
VERU News
Catalyst Timeline
0 upcoming, 0 past
No catalysts found.
Drug Pipeline
Veru-111
Respiratory Distress Syndrome, Adult
Veru-944
Prostate Cancer Metastatic
Enobosarm
Muscle Loss
Semaglutide (Wegovy) weekly injection
Obesity & Overweight
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Veru-111 | Phase 3 | Respiratory Distress Syndrome, Adult | - | - |
Veru-944 | Phase 2 | Prostate Cancer Metastatic | - | - |
Enobosarm | Phase 2 | Muscle Loss | - | - |
Semaglutide (Wegovy) weekly injection | Phase 2 | Obesity & Overweight | - | - |
Regulatory Approvals
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply